Listing & Compliance Notices

STRATA Skin Sciences, Inc. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 22, 2025, Strata Skin Sciences, Inc. (the “Company”) received a deficiency notification letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it is not in compliance with the minimum stockholders’ equity requirement for continued listing on The Nasdaq Capital Market. Nasdaq Listing Rule 5550(b)(1) requires companies listed on The Nasdaq Capital Market to maintain stockholders’ equity of at least $2,500,000 (the “Stockholders’ Equity Requirement”). On September 19, 2025, the Company submitted a plan to Nasdaq to regain compliance”

Super League Enterprise, Inc. received a nasdaq noncompliance notice notice regarding stockholders equity (rules 5550(b)(1)).

“April 7, 2025 stating that it was not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on the Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing (the “ Stockholders ’ Equity Requirement ”). The Company reported stockholders’ equity of $170,000 in its Annual Report on Form 10-K for the year ended December 31, 2024, and, as a result, it was not in compliance with the Stockholders’ Equity Requirement. The Company received a delisting determination letter on October 8, 2025 (the “ Delisting Determination Letter”

Super League Enterprise, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“er 17, 2025, and the Company’s common stock would have been delisted from Nasdaq. As of the date of this Current Report on Form 8-K, the Company requested a hearing before the Panel, at which it will request a suspension of delisting pending its return to compliance. Pursuant to Nasdaq Listing Rule 5815(a)(1)(B), the hearing request will stay the suspension of trading and delisting of the common stock pending the conclusion of the hearing process. Consequently, the Company expects the common stock to remain listed on Nasdaq at least until the Panel renders a decision following the hearing. As”

SCWorx Corp. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 8, 2025, the Company received written notification from the Listing Qualifications Department of Nasdaq, granting the Company's request for a 180-day extension to regain compliance with the Bid Price Rule. The Company now has until April 6, 2026 to meet the requirement. If at any time prior to April 6, 2026, the bid price of the Company's ordinary shares closes at $1.00 per share or more for a minimum of 10 consecutive business days, the Company will regain compliance with the Bid Price Rule. The Company is monitoring its Common Stock trading price. If compliance with the minimum bid p”

MILESTONE SCIENTIFIC INC. received a nyse_american deficiency notice notice regarding stockholders equity (rules 1003(a)(ii), 1003(a)(iii)).

“October 8, 2025, Milestone Scientific Inc. (“the Company”) received a letter from NYSE American LLC (“NYSE American” or the “Exchange”) stating that the Company is not in compliance with the continued listing standards as outlined in Section(s) 1003(a)(ii), and (iii) of the NYSE American Company Guide (the “Company Guide”). To maintain its listing, the Company must submit a plan of compliance by November 7, 2025, outlining the actions it has taken or will take to regain compliance. If the plan is accepted, the Company may be able to continue its listing but will be subject to periodic reviews”

BOLLINGER INNOVATIONS, INC. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2), 5810(c)(3)(C)).

“the “ SEC ”) on February 28, 2025, the Company received a written notice from the Staff notifying the Company that its Market Value of Listed Securities (“ MVLS ”) was less than the $35.0 million minimum required for continued listing on The Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(b)(2) (the “ MVLS Listing Rule ”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company was provided 180 calendar days, or until August 25, 2025 (the “ Compliance Period ”), to regain compliance with the MVLS Listing Rule. On August 26, 2025, as previously disclosed in a Current Re”

TON Strategy Co received a nasdaq noncompliance notice notice regarding other (rules 5635(b)).

“October 9, 2025, TON Strategy Company (the “Company”) received a letter (the “Letter”) from the staff at the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff has determined that the Company failed to comply with Nasdaq’s shareholder approval requirements set forth in Nasdaq Listing Rule 5635(b) (the “Rule”) in connection with the Company’s August 7, 2025 (the “Closing Date”), issuance of shares of common stock (“Common Stock”) (and pre-funded warrants to purchase shares of Common Stock) pursuant to that certain subsc”

enVVeno Medical Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 7, 2025, enVVeno Medical Corporation (the “Company”) received notification from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market under Rule 5550(a)(2) of Nasdaq Listing Rules. Nasdaq’s notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market. In accordance with Nasdaq Listing”

BOLLINGER INNOVATIONS, INC. received a nasdaq delisting notice notice regarding market value (rules 5550(b)(2)).

“the “ SEC ”) on February 28, 2025, the Company received a written notice from the Staff notifying the Company that its Market Value of Listed Securities (“ MVLS ”) was less than the $35.0 million minimum required for continued listing on The Nasdaq Capital Market, as required by Nasdaq Listing Rule 5550(b)(2) (the “ MVLS Listing Rule ”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company was provided 180 calendar days, or until August 25, 2025 (the “ Compliance Period ”), to regain compliance with the MVLS Listing Rule. On August 26, 2025, as previously disclosed in a Current Re”

TON Strategy Co received a nasdaq deficiency notice notice regarding other (rules 5635(b)).

“October 9, 2025, TON Strategy Company (the “Company”) received a letter (the “Letter”) from the staff at the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the Staff has determined that the Company failed to comply with Nasdaq’s shareholder approval requirements set forth in Nasdaq Listing Rule 5635(b) (the “Rule”) in connection with the Company’s August 7, 2025 (the “Closing Date”), issuance of shares of common stock (“Common Stock”) (and pre-funded warrants to purchase shares of Common Stock) pursuant to that certain subsc”

enVVeno Medical Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 7, 2025, enVVeno Medical Corporation (the “Company”) received notification from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that, because the closing bid price for the Company’s common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Capital Market under Rule 5550(a)(2) of Nasdaq Listing Rules. Nasdaq’s notice has no immediate effect on the listing of the Company’s common stock on the Nasdaq Capital Market. In accordance with Nasdaq Listing”

Carisma Therapeutics Inc. received a nasdaq delisting notice notice regarding other.

“October 9, 2025, Carisma Therapeutics Inc. (the “Company”) received a delisting determination letter (the “Determination Letter”) from The Nasdaq Stock Market LLC (“Nasdaq”). The Determination Letter indicated that, as a result of the Company’s previously disclosed noncompliance with the Nasdaq Listing Rules, the Company’s common stock will be suspended from trading on Nasdaq effective at the open of business on October 13, 2025. The Determination Letter also indicated that, after applicable appeal periods have lapsed, Nasdaq intends to file a Form 25 with the Securities and Exchange Commissio”

Beneficient received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“October 3, 2025, Beneficient (the “Company”) was notified by the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that because the Company’s Form 10-K for the fiscal year ended March 31, 2025 reported a stockholders’ equity of ($34,925,000), the Company was in non-compliance with the minimum stockholders’ equity requirement set forth in Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”), which could also serve as a separate and additional basis for delisting in addition to the matters described below (such letter, the “Additional Determination Le”

BullFrog AI Holdings, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5550(b)(1)).

“October 7, 2025, the Company received a letter (the “Extension Letter”) from Nasdaq informing the Company that, based on the Company’s plan, the Company was granted an extension of time to regain compliance with the Stockholder Equity Requirement. In accordance with the Extension Letter, the Company now has 180 calendar days from the date of the Notice Letter, or until February 17, 2026, to regain compliance with the Stockholder Equity Requirement. If the Company does not regain compliance with the Stockholder Equity Requirement by the end of this compliance period, the Company’s common stock”

Datacentrex, Inc. received a nasdaq noncompliance notice notice regarding audit committee (rules 5605(c), 5605(c)(4), 10A-3).

“October 9, 2025, the Company was notified by Nasdaq of its non-compliance. Nasdaq Listing Rule 5605(c) requires, among other things, that the Company have an audit committee that has at least three members, each of whom must (i) be an Independent Director (as defined in Nasdaq Listing Rule 5605(a)(2)), (ii) meet the criteria for independence set forth in Rule 10A-3(b)(1) under the Securities Exchange Act of 1934, as amended, (iii) not have participated in the preparation of the financial statements of the Company or any current subsidiary of the Company at any time during the past three years”

SHINECO, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 3, 2025, Nasdaq informed the Company that the stay had been lifted and that trading in the Company’s common stock would be suspended effective at the open of trading on Tuesday, October 7, 2025. The Company has indicated its intent to appeal the Listing Council’s decision to the Securities and Exchange Commission (“SEC”) pursuant to Sections 19(d) and 19(f) of the Securities Exchange Act of 1934, as amended. In the interim, on October 6, 2025, the Company filed an emergency petition with the United States Court of Appeals for the D.C. Circuit, seeking to enjoin Nasdaq from implementing”

SHINECO, INC. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 1, 2025, affirming the Panel’s decision to delist the Company’s securities (the “Listing Council Decision”). On October 3, 2025, Nasdaq informed the Company that the stay had been lifted and that trading in the Company’s common stock would be suspended effective at the open of trading on Tuesday, October 7, 2025. The Company has indicated its intent to appeal the Listing Council’s decision to the Securities and Exchange Commission (“SEC”) pursuant to Sections 19(d) and 19(f) of the Securities Exchange Act of 1934, as amended. In the interim, on October 6, 2025, the Company filed an eme”

DIH HOLDING US, INC. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A)).

“September 2, 2025, the Staff notified the Company that its securities were subject to delisting from Nasdaq unless the Company timely requests a hearing before the Panel. As previously disclosed, on March 11, 2025, the Company received written notice from Staff which notified the Company that the bid price of its Class A common stock had closed at less than $1.00 per share for the previous 30 consecutive business days prior to the date of the Bid Price Notice, as required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “Bid Price Rule”). In accord”

DIH HOLDING US, INC. received a nasdaq hearing update notice regarding market value (rules 5450(b)(2)(C)).

“October 7, 2025, (the “October Letter”) the Company received formal notification from the Staff that the Nasdaq Hearings Panel (the “Panel”) will consider this matter in rendering a determination regarding the Company’s continued listing on The Nasdaq Global Market. The October Letter provided that pursuant to Listing Rule 5810(d), the Company should present its views with respect to this additional deficiency at its Panel hearing. If the Company fails to address the aforementioned issue, the Panel will consider the record as presented at the hearing and will make its determination based upon”

Nexentis Technologies Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

“October 6, 2025, N2OFF, Inc. (the “Company”) received a written notification (the “Notification”) from the Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company has regained compliance with the Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share for the Company’s common stock. As previously reported, on March 28, 2025, the Company received notice from Nasdaq that it was not in compliance with the minimum bid price requirement. The Notification states that for 10 consecutive business days from September 22, 2025 through October 3, 2025, the closing bid”

DIH HOLDING US, INC. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(A), 5810(c)(3)(C)).

“March 5, 2025, the Company received written notice from Staff which notified the Company that, for the previous 30 consecutive business days prior to the date of the MVLS Notice, the Company’s market value of listed securities (“MVLS”) closed below the $50,000,000 MVLS threshold required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “MVLS Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company was provided with a compliance period of 180 calendar days in which to regain compliance with the MVLS continued listing requirement, or”

DIH HOLDING US, INC. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C), 5810(c)(3)(D)).

“April 4, 2025, the Listing Qualifications Staff (“Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) notified DIH Holding US, Inc. (the “Company”) that for the previous 30 consecutive trading days the market value of its publicly held shares had been below the minimum $15,000,000 required for continued listing as set forth in Listing Rule 5450(b)(2)(C) (the “MVPHS Rule”). Therefore, in accordance with Marketplace Rule 5810(c)(3)(D), the Company was provided 180 calendar days, or until October 1, 2025, to regain compliance with the Rule. The Company has not regained compliance with the Rule. Acc”

ADDENTAX GROUP CORP. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“April 9, 2025, from the Listings Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that the minimum bid price per share of its common stock, par value $0.001 per share (the “Common Stock”), was below $1.00 for a period of 30 consecutive business days and that the Company did not meet the minimum bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Price Rule”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A), Nasdaq granted the Company 180 days, or until October 6, 2025, to regain compliance with the Minimum Bid”

urban-gro, Inc. received a nasdaq delisting notice notice regarding stockholders equity (rules 5550(b)(1)).

“August 18, 2025, Nasdaq notified the Company that it had determined (the “Prior Determination”) that the Company was not in compliance with the Timely Filing Requirement and the Stockholders’ Equity Requirement. The Company requested a hearing before the Panel, which hearing has been rescheduled from the previously-reported date of October 7, 2025 to October 14, 2025. There can be no assurance that the Company will be able to regain compliance with Nasdaq Listing Rules 5550(a)(2), 5250(c)(1) and/or 5550(b)(1), or will otherwise be in compliance with other applicable Nasdaq Listing Rules, or th”

urban-gro, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2)).

“August 28, 2025, the Company received a determination letter (the “Determination”) from Nasdaq stating that Nasdaq had determined that the Company did not regain compliance with the Minimum Bid Requirement by August 25, 2025. The Determination stated that the failure to comply with the Minimum Bid Requirement during the compliance period would serve as an additional basis for delisting the Company’s securities from the Nasdaq Capital Market and would be considered by a Hearings Panel (the “Panel”), in addition to the Company’s failure to comply with (i) Nasdaq Listing Rule 5250(c)(1) due to th”

urban-gro, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“August 18, 2025, Nasdaq notified the Company that it had determined (the “Prior Determination”) that the Company was not in compliance with the Timely Filing Requirement and the Stockholders’ Equity Requirement. The Company requested a hearing before the Panel, which hearing has been rescheduled from the previously-reported date of October 7, 2025 to October 14, 2025. There can be no assurance that the Company will be able to regain compliance with Nasdaq Listing Rules 5550(a)(2), 5250(c)(1) and/or 5550(b)(1), or will otherwise be in compliance with other applicable Nasdaq Listing Rules, or th”

urban-gro, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“February 24, 2025, urban-gro, Inc. (the “Company”) received a deficiency letter from the Listing Qualifications Department of Nasdaq notifying the Company that, for the last 30 consecutive business days, the bid price for the Company’s common stock, par value $0.001 per share (the “Common Stock”) had closed at a price of below $1.00 per share, which is the minimum closing price required to maintain continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2) (the “Minimum Bid Requirement”). Also as previously reported, on August 28, 2025, the Company received a determina”

Adicet Bio, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5450(a)(1), 5550(a)(2), 5810(c)(3)(A)).

“October 7, 2025, the Company received a notice (the Extension Notice) from Nasdaq informing the Company that Nasdaq has granted the Company an additional 180 calendar days, or until April 6, 2026, to regain compliance with the Bid Price Requirement for continued listing on the Nasdaq Capital Market under Nasdaq Listing Rule 5550(a)(2). In connection with the Extension Notice, the listing of the Common Stock will be transferred from the Nasdaq Global Market to the Nasdaq Capital Market, effective at the opening of business on October 9, 2025. The Extension Notice has no other immediate effect o”

Origin Materials, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 7, 2025, the Company received written notice from Nasdaq notifying the Company that it has determined that the Company is eligible for an additional 180-day calendar period, or until April 6, 2026, to regain compliance. The determination is based upon the Company meeting the applicable market value of publicly held shares requirement for continued listing and all other applicable requirements for initial listing on The Nasdaq Capital Market (except for the Minimum Bid Requirement), the Company’s written notice of its intention to cure the deficiency by effecting a reverse stock split”

Nuburu, Inc. received a nyse_american noncompliance notice notice regarding audit committee (rules 303A.12(b)).

“October 7, 2025, as required by Section 303A.12(b) of the NYSE Listed Company Manual, the Company submitted an interim written affirmation to the NYSE American Market (the “Exchange”) as a notice of non-compliance with Section 803B(2)(c) of the NYSE American Company Guide (the “Company Guide”), since the Audit Committee is no longer comprised of at least two independent directors. Pursuant to Section 803B(6)(b) of the Company Guide, the Company has until the earlier of its next annual meeting of stockholders or one year from the occurrence of the event that caused the failure to comply with th”

BRC Group Holdings, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5800).

“fect and will not immediately result in the suspension of trading or delisting of the Company’s securities. The Staff Determination Letter notified the Company that it may request a hearing before a Nasdaq Hearings Panel (“Hearings Panel”), pursuant to the procedures set forth in the Nasdaq Listing Rule 5800 Series. A request for a hearing regarding one or more delinquent filings will automatically stay the suspension of the Company’s securities for a period of at least 15 calendar days from the date of the hearing request. By Nasdaq rule, when a company requests a hearing for one or more late”

Werewolf Therapeutics, Inc. received a nasdaq noncompliance notice notice (rules 5605(c)(2), 5605(c)(4)(B)).

“October 2, 2025, the Company notified Nasdaq of the resulting non-compliance with Nasdaq listing rules caused by Dr. Lazarus’s passing. Pursuant to Nasdaq Listing Rule 5605(c)(4)(B), the Company is entitled to a cure period to regain compliance with Nasdaq Listing Rule 5605(c)(2), which cure period will expire upon the earlier of the Company’s next annual meeting of stockholders or September 30, 2026. The Company also informed Nasdaq that the Board plans to regain compliance with the listing rules at its earliest opportunity by appointing an additional independent director of the Company to fi”

HARVARD BIOSCIENCE INC received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“October 2, 2025, Harvard Bioscience, Inc., (the “Company”) received a notification letter from the Nasdaq Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it had been granted an additional 180 days, or until March 30, 2026 (the “Second Compliance Period”), to regain compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market under Nasdaq Marketplace Rule 5550(a)(2), which requires a minimum bid price of $1.00 per share (the “Minimum Bid Price Requirement”), based on the Company meeting”

Cytosorbents Corp received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

“October 2, 2025, CytoSorbents Corporation (the “Company”) received written notice from the Listing Qualifications Department of the Nasdaq Stock Market LLC (“Nasdaq”) that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2) because the Company’s common stock had fallen below $1.00 per share for 30 consecutive business days (the “Minimum Bid Price Requirement”). The written notification has no immediate effect on the listing or trading of the Company’s common stock. In accordance with applicable Nasdaq rules, the Company has 180 calendar days following the date of the written”

zSpace, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(2)(C)).

“October 1, 2025, zSpace, Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department (the “Staff”) of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that the Company is not in compliance with the continued listing requirement set forth in Nasdaq Listing Rule 5450(b)(2)(C), which requires listed companies to maintain a minimum market value of publicly held shares (“MVPHS”) of at least $15,000,000. Based on the Staff’s review of the Company’s MVPHS, the Company’s MVPHS was below $15 million for the previous 30 consecutive business days. The Notice”

Azitra, Inc. received a nyse_american noncompliance notice notice regarding stockholders equity (rules 1003(a)(ii), 1009).

“October 1, 2025, Azitra, Inc. (the “Company”) received notification (the “Letter”) from the NYSE American LLC (the “NYSE American”) stating that the Company is not in compliance with the minimum stockholders’ equity requirement of Section 1003(a)(ii) of the NYSE American Company Guide (the “Company Guide”) requiring stockholders’ equity of $4.0 million or more if the Company has reported losses from continuing operations and/or net losses in three of the four most recent fiscal years. As of June 30, 2025, the Company had stockholders’ equity of $2.2 million and has had losses in three of its f”

Corvex, Inc. received a nasdaq deficiency notice notice regarding stockholders equity (rules 5550(b)(1)).

“October 1, 2025, Movano Inc. (the “Company”) received a written notice (the “Notice”) from the Listing Qualifications Department of Nasdaq Stock Market (“Nasdaq”) indicating that it is not in compliance with Nasdaq Listing Rule 5550(b)(1), which requires companies listed on The Nasdaq Capital Market to maintain a minimum of $2,500,000 in stockholders’ equity for continued listing (the “Stockholders’ Equity Requirement”) and serves as an additional basis of delisting before the Nasdaq Hearings Panel (the “Panel”). In its Quarterly Report on Form 10-Q for the fiscal year ended June 30, 2025, fil”

Kaival Brands Innovations Group, Inc. received a nasdaq extension granted notice regarding minimum bid price (rules 5550(a)(2)).

“October 2, 2025, the Company received a second letter from Nasdaq granting the Company’s request for a 180-day extension to regain compliance with the Bid Price Rule. The Company now has until March 30, 2026, to meet the requirement. As part of the Company’s request for the 180-day extension, the Company notified Nasdaq that it intends to regain compliance with the Bid Price Rule by effecting a reverse stock split, if necessary. If at any time prior to March 30, 2026, the bid price of the Company’s common stock closes at $1 per share or more for a minimum of 10 consecutive business days, the C”

Stardust Power Inc. received a nasdaq delisting notice notice regarding market value (rules 5450(b)(2)(A)).

“hich may include a transfer to the Nasdaq Capital Market listing tier. As previously reported by Stardust on March 24, 2025, the Company received deficiency letters from the Staff on March 18, 2025, and March 19, 2025, notifying the Company that it was not in compliance with (i) Nasdaq Listing Rule 5450(b)(2)(C) requiring a listed company to maintain a minimum Market Value of Publicly Held Shares, as defined by Nasdaq, of $15 million and (ii) Nasdaq Listing Rule 5450(a)(1) requiring a listed company to maintain a minimum bid price of $1.00 per share, respectively (such requirements, the “ List”

Xilio Therapeutics, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1), 5810(c)(3)(H)).

“April 8, 2025 , the Company received a letter from the Staff of Nasdaq notifying the Company of its failure to maintain the $1.00 minimum bid price required for continued listing on The Nasdaq Global Select Market under Nasdaq Listing Rule 5450(a)(1) (the “Minimum Bid Price Requirement”). In connection with the transfer to The Nasdaq Capital Market, Nasdaq granted the Company an additional 180 calendar day period, or until March 30, 2026, to regain compliance with the Minimum Bid Price Requirement. During the additional 180 calendar day grace period, the Company’s common stock must close at $1”

Aeries Technology, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“October 3, 2025 AERIES TECHNOLOGY, INC. A Cayman Islands exempted company By: /s/ Daniel S. Webb Name: Daniel S. Webb Title: Chief Finan”

Abpro Holdings, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(a)(1)).

“September 30, 2025, the Company received a letter from Nasdaq notifying the Company that it had not regained compliance with the Minimum Bid Price Requirement during the compliance period. Accordingly, unless the Company requests an appeal by October 7, 2025, the Company’s common stock will be scheduled for delisting at the opening of business on October 9, 2025. Accordingly, the Company intends to timely request a hearing before the appeal panel (the “Panel”). The hearing request will stay the suspension of the Company’s securities with Nasdaq pending the Panel’s decision or any extension of”

REPUBLIC AIRWAYS HOLDINGS INC. received a nasdaq noncompliance notice notice regarding other (rules 5810(c)(2)(G)).

“ear end, prior to Mesa’s recently announced change to a December 31 fiscal year end). The Notice is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on Nasdaq Capital Market. Pursuant to Nasdaq Listing Rule 5810(c)(2)(G), the Notice states that the Company has 45 calendar days, or until November 17, 2025, to submit a plan to regain compliance with the Annual Shareholders Meeting Rule. The Company intends to submit a plan to regain compliance with the Annual Shareholders Meeting Rule within the required”

IMMERSION CORP received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).

“otification Letter”) from Nasdaq notifying the Company that it did not timely file its Annual Report on Form 10-K for the fiscal year ended April 30, 2025 (the “Form 10-K”). Both the Form 10-Q and the Form 10-K are required to be filed for continued listing on Nasdaq pursuant to Nasdaq Listing Rule 5250(c)(1). Under Nasdaq rules, the Company has 60 calendar days from the date of the 10-K Nasdaq Notification Letter, or October 20, 2025, to submit to Nasdaq a plan to regain compliance with Nasdaq Listing Rule 5250(c)(1). If Nasdaq accepts the plan, the Company will have until February 9, 2026 to”

CBAK Energy Technology, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).

“October 1, 2025, CBAK Energy Technology, Inc. (the “Company”) received notice (the “Notice”) from the Listing Qualifications staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is currently not in compliance with the minimum bid price requirement set forth under Nasdaq Listing Rule 5550(a)(2), which requires listed securities to maintain a minimum bid price of US$1.00 per share. Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency continues for a period of 30 consecutive business days. Based on th”

VEEA INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A), 5810(c)(3)(H)).

“September 29, 2025, Veea Inc., a Delaware corporation (the “ Company ”), received a notice from the Listing Qualifications Department (the “ Staff ”) of The Nasdaq Stock Market LLC (“ Nasdaq ”), notifying the Company that, because the closing bid price for its common stock has fallen below $1.00 per share for 30 consecutive business days, the Company no longer complies with the minimum bid price requirement for continued listing on the Nasdaq Global Market under Nasdaq Lising Rule 5550(a)(2) (the “ Minimum Bid Price Requirement ”). The notice has no immediate effect on the listing of the Compa”

Bolt Projects Holdings, Inc. received a nasdaq extension granted notice regarding stockholders equity (rules 5450(b)(2)(A), 5450(b)(2)(C), 5550(b)(1)).

“September 30, 2025, the Company received written notification from the Panel (the “Determination Letter”) granting the Company’s request for an extension to regain compliance with Nasdaq’s listing standards based on the compliance plan presented at the Company’s hearing before the Panel. As part of that plan, the Company presented a timeline of achieving compliance by December 31, 2025, which date is within the Panel’s authority under Nasdaq Listing Rule 5815 to grant an extension of up to 180 days. Pursuant to the Determination Letter, the Company is to gain compliance with the minimum equity”

DIH HOLDING US, INC. received a nasdaq delisting notice notice regarding late filing (rules 5250(c)(1)).

“ailed to regain compliance under Bid Price Rule, so this matter was an additional basis for delisting. The Company is clarifying that since it was not current in filing its Form 10-Q for the period ended June 30, 2025, and Form 10-K for the fiscal year ended March 31, 2025 under Nasdaq Listing Rule 5250(c)(1) (the “Reports Rule”), this matter was also included as an additional basis for delisting in the September 12, 2025 notice. Therefore, the Company needs to address its non-compliance with the Reports Rule with the Panel. The Company has requested a hearing before the Panel, which has staye”

DIH HOLDING US, INC. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5450(b)(2)(A), 5810(c)(3)(C)).

“March 11, 2025, DIH Holding US, Inc. (the “Company”) received written notice (the “Bid Price Notice”) from the Listing Qualifications Staff (“Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) which notified the Company that the bid price of its Class A common stock had closed at less than $1.00 per share for the previous 30 consecutive business days prior to the date of the Bid Price Notice , as required for continued listing on the Nasdaq Global Market under Nasdaq Listing Rule 5450(b)(2)(A) (the “Bid Price Rule”). In accordance with Nasdaq Listing Rule 5810(c)(3)(C), the Company was provided”

Newton Golf Company, Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605(c)(2)).

“October 2, 2025, the Company also received a notice from Nasdaq, notifying the Company that, as a result of Ms. Pepper’s resignation, the Company is not in compliance with Nasdaq Listing Rules 5605(b)(1) and 5605(c)(2). Nasdaq Listing Rules 5605(b)(1)(A) and 5605(c)(4) provide a cure period for these deficiencies until the earlier of (i) the Company’s next annual stockholders’ meeting or (ii) September 29, 2026; however, if the Company’s next annual stockholders’ meeting is held before March 27, 2026, then the cure period will continue through March 27, 2026. The Company intends to appoint an”